Updated Jul 16, 2026
Kaplan Johanne has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $25K.
Johanne Kaplan serves as the Chief Development Officer at ProMIS Neurosciences Inc., a clinical-stage biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases. With a background in biotechnology, she plays a key role in the company's development efforts.
| Role | Chief Development Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-23 | PMN | ProMIS Neurosciences Inc. | P — Open-market purchase | 1.6K | $15.35 | $25K |
| 2026-02-06 | PMN | ProMIS Neurosciences Inc. | A — Grant or award | 2.1K | $12.13 | $25K |
Johanne Kaplan serves as the Chief Development Officer at ProMIS Neurosciences Inc., a clinical-stage biotechnology company focused on developing antibody therapeutics for neurodegenerative diseases. With a background in biotechnology, she plays a key role in the company's development efforts.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($25K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kaplan Johanne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.